Status:
WITHDRAWN
Cost Utility Analysis in Recurrent Ovarian Cancer
Lead Sponsor:
M.D. Anderson Cancer Center
Conditions:
Ovarian Cancer
Eligibility:
FEMALE
Brief Summary
The goal of this research study is to learn about the quality of life and sexual functioning of women with platinum-resistant ovarian cancer as they receive other treatments for the disease. Research...
Detailed Description
Study Participation: If you agree to take part in this study, medical and demographic information will be collected from your medical record and/or by asking you in person when you come to the clinic...
Eligibility Criteria
Inclusion
- Patients with recurrent, platinum-resistant epithelial ovarian cancer who are beginning any second-line treatment
- Patients must be English-speaking
- Patients must be able to read and write English
- Patients receiving all chemotherapy at MD Anderson Cancer Center
Exclusion
- Patients with non-epithelial ovarian cancers including sex-cord stromal tumors, germ cell tumors, low-grade tumors, and metastatic disease to the ovary
- Patients who are receiving protocol therapy
- Patients who have had a prior diagnosis of invasive cancer at other sites (excluding basal cell carcinoma of the skin)
- Patients who are receiving radiation therapy as a treatment modality
Key Trial Info
Start Date :
December 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2011
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00813254
Start Date
December 1 2008
End Date
January 1 2011
Last Update
April 19 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UT MD Anderson Cancer Center
Houston, Texas, United States, 77030